logo
episode-header-image
Dec 2022
33m 37s

HIBT Lab! Immunai: Noam Solomon

Guy Raz | Wondery
About this episode
According to the CDC, 6 in 10 adults in the U.S. have a chronic disease like cancer or diabetes. Meanwhile, the process for discovering new drug treatments is critically expensive and inefficient. About 90% of drug candidates fail to gain FDA approval; the average cost to develop a new drug is over $1 billion; and testing can take over 10 years.Noam Solomon ... Show More
Up next
Aug 17
Bobbie: Laura Modi. How a Baby Formula Startup Took Market Share From Two Industry Giants
Laura Modi set out to build a better infant formula. What followed was years of setbacks: a crippling dispute with the FDA, a frustrating search for a manufacturer, and the constant fear that the company would run out of money before it reached customers.But today, Bobbie generat ... Show More
1h 19m
Aug 13
Advice Line with Bobbi Brown of Jones Road Beauty (September 2025)
Today's callers: Bob in Chicago looks to promote his cabbage-based muscle and joint rub beyond the walls of his orthopedic practice. Then Abby in Dallas wonders whether her popular social media livestreams are a sustainable way to market her trendy phone cases. And Henry in Charl ... Show More
48m 21s
Aug 10
MadeGood: Salma and Nima Fotovat Lost Their First Business. They Grew Their Next One Into a Snack Giant.
What do you do when the family business you've spent decades building... gets bought out from under you? That’s what happened to Nima and Salma Fotovat.Devastated, the family rebuilt a new company from the ground up. This time they set out with a new idea: build an allergen-free, ... Show More
1h 5m
Recommended Episodes
Jul 2022
Immunai CTO and Co-Founder Luis Voloch on Using Deep Learning to Develop New Drugs - Ep. 176
What if we could map our immune system to create drugs that can help our bodies win the fight against cancer and other diseases? That’s the big idea behind immunotherapy. The problem: the immune system is incredibly complex. Enter Immunai, a biotechnology company that’s using AI ... Show More
27m 52s
Mar 2025
Episode 54: Can AI Transform Drug Development? With Dr Scott Chetham, CEO of Faro Health
It’s widely assumed that drug treatment is a miracle of modern science. However, it’s equally arguable that modern drug treatment is a very expensive disaster, with serious consequences for public health. For example, a drug typically takes 10-12 years to develop and the cost is ... Show More
34m 33s
Apr 2020
Curing Disease With Data
It can take 15 years to get one life-saving drug to market. Cutting-edge scientists are finding new ways to shift through unimaginable quantities of data faster than ever before. -- This program is produced by Mission.org and brought to you by Splunk, the Data-to-Everything Platf ... Show More
15m 18s
Oct 2024
EP 159: Engineering macrophages to tackle rare disease with Noam Baumatz of Noga Therapeutics
In this episode, we’re joined by Noam Baumatz, CEO and Co-Founder of Noga Therapeutics, a company dedicated to developing gene therapies for rare and severe diseases through engineering macrophages. Motivated by his highly personal experience of rare disease, Noam founded Noga to ... Show More
44m 17s
Nov 2025
How AI Will Accelerate Breakthroughs in Biotechnology with Benchling CEO Sajith Wickramasekara
Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the centra ... Show More
48m 13s
Jun 2025
Will AI Finally Defeat Chronic Diseases Like Alzheimer’s?
The pharmaceutical industry has yet to develop highly effective treatments for common chronic and neurological issues, like Alzheimer’s and cardiovascular disease. But GenAI promises to accelerate the discovery and development of breakthrough treatments. BCG’s Priya Chandran expl ... Show More
28m 43s
Feb 2024
Moderna and Drug Discovery With AI
Vaccine-maker Moderna is also a data company, and that’s enabling it to use AI to drastically reduce drug-development times, Chief Information Officer Brad Miller tells Bloomberg Intelligence’s Sam Fazeli and Mandeep Singh. This episode of the Tech Disruptors podcast looks at a w ... Show More
36m 35s
Aug 2020
The Promise of a New Treatment
The drug company Eli Lilly is about to start testing its Covid-19 antibody drug in nursing homes. Vaccines may not work as well on elderly people or those with compromised immune systems. Since these are the very groups most at risk for severe disease or death if they contract th ... Show More
11m 32s
Jun 2025
Novartis CEO: Medical Innovation, Tech Partnerships, and European Competitiveness
Can AI help us find cures for diseases we've never been able to treat? Nicolai Tangen speaks with Vasant 'Vas' Narasimhan, CEO of Novartis, about pioneering pharmaceutical innovation. They explore breakthrough cell and gene therapies, AI partnerships with leading tech companies, ... Show More
46m 34s
Dec 2020
The Challenges of Bringing AI into the Pharmaceutical Industry - with Kristof Szalay of Turbine.AI
Today's guest is the great and brilliant Dr. Kristof Szalay, CTO and Founder of Turbine.AI. Turbine's AI-driven platform understands cancer's inner mechanisms, enabling the discovery of novel targets & precision medicinal therapies. Episode topics include: dynamics of pharmaceuti ... Show More
17m 42s
Listen to millions of songs and podcasts on Anghami